Telocinobufagin

CAS No. 472-26-4

Telocinobufagin( Telobufotoxin | Telocinobufogenin )

Catalog No. M18585 CAS No. 472-26-4

Telocinobufagin is the major endogenous digitalis-like factor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 140 In Stock
5MG 125 In Stock
10MG 200 In Stock
25MG 356 In Stock
50MG 512 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Telocinobufagin
  • Note
    Research use only, not for human use.
  • Brief Description
    Telocinobufagin is the major endogenous digitalis-like factor.
  • Description
    Telocinobufagin is the major endogenous digitalis-like factor. Telocinobufagin significantly decreases the bacterial burdens in the spleen and prolongs the survival time of FIST-immunized mice challenged with live S. typhimurium. Telocinobufagin has immunomodulatory activity, can enhance a Th1 immune response to control intracellular infections, could be developed as a novel immunotherapeutic agent to treat cancer and other immune-mediated diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Telobufotoxin | Telocinobufogenin
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    472-26-4
  • Formula Weight
    402.53
  • Molecular Formula
    C24H34O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (124.22 mM)
  • SMILES
    CC12CCC(CC1(CCC3C2CCC4(C3(CCC4C5=COC(=O)C=C5)O)C)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Methyl?Dihydrojasmon...

    Methyl dihydrojasmonate is an ester and a diffusive aroma compound, with the smell vaguely similar to jasmine.

  • Zanthobungeanine

    Zanthobungeanine has anti-inflammatory activity, it shows moderate NO production inhibitory activity with an IC50 value of 37.26 mg /L.It shows obviously inhibitoryactivity to platelet aggregation caused by platelet-activating factor (PAF). Zanthobungeanine shows the inhibitory action on the development of A549 cell only in high concentration and has no antipersonnel effect on A549 cell.

  • Foslinanib

    Foslinanib (TRX-818) is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities.